Immunohistochemistry (IHC) staining of CACNA2D1 was performed in clinical NPC patients to examine the expression of CACNA2D1 in matched normal and tumour regions scored by a pathologist. This evidence concerns the gene CACNA2D1 and nasopharyngeal carcinoma.